Differences in the cognitive status of patients with schizophrenia depending on the genesis of concomitant encephalopathy

Close metadata

OBJECTIVE

To analyze the cognitive status of patients with schizophrenia and organic cerebral pathology of various genesis.

MATERIAL AND METHODS

The study included 75 patients diagnosed with paranoid schizophrenia (F20.0). Depending on the type of organic brain lesion, all patients were divided into four groups: patients with paranoid schizophrenia without organic brain pathology (n=41), patients with dyscirculatory encephalopathy (n=15), patients with post-traumatic encephalopathy (n=12), patients with toxic encephalopathy (n=7).The Brief Assessment of Cognition in Schizophrenia (BACS) and the Rey-Osterrieth Complex Figure (ROCF) followed by the evaluation of the results with the Boston Qualitative Scoring System (BQSS)were used to assess the cognitive status.

RESULTS AND CONCLUSION

Patients with schizophrenia without concomitant cerebral pathology had a better state of the cognitive sphere compared to patients whose underlying disease was aggravated by encephalopathy of various genesis. In particular, it applied to such cognitive functions as verbal memory, speech fluency, problem-solving behavior, long-term visual-motor memory, organization and constructive ability. According to the results of this study, patients with posttraumatic encephalopathy had the least pronounced cognitive deficit among patients with an organic brain lesion. In turn, patients with toxic encephalopathy had the worst indicators of the state of the cognitive sphere.

Keywords:

schizophrenia

cognitive disorders

encephalopathy

concomitant pathology

Authors:

Kolesnikov D.A.

State Establishment of Lugansk People’s Republic Saint Luka Lugansk State Medical University

Kondufor O.V.

State Establishment of Lugansk People’s Republic Saint Luka Lugansk State Medical University

Rachkauskas G.S.

State Establishment of Lugansk People’s Republic Saint Luka Lugansk State Medical University

Received:

13.04.2021

Accepted:

24.08.2021

List of references:

O’Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, De Carli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurology. 2003;2(2):89-98. https://doi.org/10.1016/S1474-4422(03)00305-3
Solé B, Jiménez E, Torrent C, Reinares M, del Mar Bonnin C, Torres I, Varo C, Grande I, Valls E, Salagre E, Sanchez-Moreno J, Martinez-Aran A, Carvalho AF, Vieta E. Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies. International Journal of Neuropsychopharmacology. 2017;20(8):670-680. https://doi.org/10.1093/ijnp/pyx032
Dorofeikova M, Neznanov N, Petrova N. Cognitive deficit in patients with paranoid schizophrenia: Its clinical and laboratory correlates. Psychiatry Research. 2018;262:542-548. https://doi.org/10.1016/j.psychres.2017.09.041
Rosca EC, Cornea A, Simu M. Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review. General Hospital Psychiatry. 2020;65:64-73. https://doi.org/10.1016/j.genhosppsych.2020.05.011
Dacquino C, De Rossi P, Spalletta G. Schizophrenia and bipolar disorder: The road from similarities and clinical heterogeneity to neurobiological types. Clinica Chimica Acta. 2015;449:49-59. https://doi.org/10.1016/j.cca.2015.02.029
Birur B, Kraguljac NV, Shelton RC, Lahti AC. Brain structure, function, and neuroche mistry in schizophrenia and bipolar disorder — a systematic review of the magnetic resonance neuroimagingliterature. NPJ Schizophrenia. 2017;3:15. https://doi.org/10.1038/s41537-017-0013-9
Dietsche B, Kircher T, Falkenberg I. Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies. Australian and New Zealand Journal of Psychiatry. 2017;51(5):500-508. https://doi.org/10.1177/0004867417699473
Brugger SP, Howes OD. Heterogeneity and Homogeneity of Regional Brain Structure in Schizophrenia: A Meta-analysis. JAMA Psychiatry. 2017;74(11):1104-1111. https://doi.org/10.1001/jamapsychiatry.2017.2663
Ceaser AE, Barch DM. Striatal Activity is Associated with Deficits of Cognitive Control and Aberrant Salience for Patients with Schizophrenia. Frontiers in Human Neuroscience. 2016;9:687. https://doi.org/10.3389/fnhum.2015.00687
Katamanova EV, Rukavishnikov VS, Lakhman OL, Shevchenko OI, Denisova IA. Cognitive impairment in a toxic lesion ofthe brain. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(2):11-15. (In Russ.). https://doi.org/10.17116/jnevro20151152111-15
Omalu B. Chronic Traumatic Encephalopathy. Concussion. 2014;28:38-49. https://doi.org/10.1159/000358761
Dichgans M, Leys D. Vascular Cognitive Impairment. Circulation Research. 2017;120(3):573-591. https://doi.org/10.1161/CIRCRESAHA.116.308426
Parfenov VA. Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):61-67. (In Russ.). https://doi.org/10.14412/2074-2711-2019-3S-61-67
Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: the Baltimore longitudinal study of aging. Hypertension. 2005;45(3):374-379. https://doi.org/10.1161/01.HYP.0000156744.44218.74
Paradise MB, Glozier NS, Naismith SL, et al. Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: a cross-sectional study. BMC Psychiatry. 2011;11:108. https://doi.org/10.1186/1471-244X-11-108
Adams ML, Grandpre J, Katz DL, Shenson D. Cognitive Impairment and Cardiovascular Disease: A Comparison of Risk Factors, Disability, Quality of Life, and Access to Health Care. Public Health Rep. 2020;135(1):132-140. https://doi.org/10.1177/0033354919893030
Yakhno NN, Preobrazhenskaya IS, Zakharov VV, Stepkina DA, Lokshina AB, Mkhitaryan EA, Koberskaya NN, Savushkina IY. Prevalence of cognitive impairments in neurological diseases: Analysis of the activities of a specialized outpatient reception office. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;2:30-35. (In Russ.). https://doi.org/10.14412/2074-2711-2012-378
Neverovsky DV, Sluchevskaya SF, Parfenov VA. Differential diagnosis of dyscirculatory encephalopathy in outpatient practice. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;2:38-42. (In Russ.). https://doi.org/10.14412/2074-2711-2013-2
Preobrazhenskaya IS. Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy. Nevrologiya, Neiropsikhiatriya, Psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2013;4:71-77. (In Russ.). https://doi.org/10.14412/2074-2711-2013-2459
Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72(1):41-51. https://doi.org/10.1016/j.schres.2004.09.009
Green MF, Harvey PD. Cognition in schizophrenia: Past, present, and future. Schizophrenia Research: Cognition. 2014;1(1):1-9. https://doi.org/10.1016/j.scog.2014.02.001

Close metadata